Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Clinical trial NCT06810778 · RECRUITING

Trial details

NCT number: NCT06810778
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-cell-prolymphocytic Leukemia Cutaneous T-Cell Lymphoma Refractory

Start date: 2025-05-02
Primary completion: 2030-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.